{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T03:57:11Z","timestamp":1784779031081,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.neulet.2017.09.051","type":"journal-article","created":{"date-parts":[[2017,9,29]],"date-time":"2017-09-29T13:47:34Z","timestamp":1506692854000},"page":"51-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Integrated microarray analysis provided a new insight of the pathogenesis of Parkinson\u2019s disease"],"prefix":"10.1016","volume":"662","author":[{"given":"Ping","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shishuang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benshu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2017.09.051_bib0005","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/ajmg.b.32288","article-title":"Alpha-synuclein (SNCA) polymorphisms and susceptibility to Parkinson\u2019s disease: a meta-analysis","volume":"168","author":"Han","year":"2015","journal-title":"Am. J. Med. Genet. Part B Neuropsychiatr. Genet."},{"key":"10.1016\/j.neulet.2017.09.051_bib0010","doi-asserted-by":"crossref","first-page":"e0133776","DOI":"10.1371\/journal.pone.0133776","article-title":"Genetic variants of SNCA are associated with susceptibility to Parkinson\u2019s disease but not amyotrophic lateral sclerosis or multiple system atrophy in a Chinese population","volume":"10","author":"Chen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neulet.2017.09.051_bib0015","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.freeradbiomed.2013.10.008","article-title":"\u03b1-Synuclein and mitochondrial bioenergetics regulate tetrahydrobiopterin levels in a human dopaminergic model of Parkinson disease","volume":"67","author":"Ryan","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neulet.2017.09.051_bib0020","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.bbadis.2016.01.022","article-title":"Adaptation within mitochondrial oxidative phosphorylation supercomplexes and membrane viscosity during degeneration of dopaminergic neurons in an animal model of early Parkinson\u2019s disease","volume":"1862","author":"Kuter","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neulet.2017.09.051_bib0025","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.conb.2012.11.002","article-title":"Mitochondrial quality control turns out to be the principal suspect in parkin and PINK1-related autosomal recessive Parkinson\u2019s disease","volume":"23","author":"Corti","year":"2013","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neulet.2017.09.051_bib0030","article-title":"Variants in GBA, SNCA, and MAPT influence Parkinson disease risk, age at onset, and progression","volume":"37","author":"Davis","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neulet.2017.09.051_bib0035","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.bbadis.2014.02.010","article-title":"Effect of resveratrol on mitochondrial function: implications in parkin-associated familiar Parkinson\u2019s disease","volume":"1842","author":"Ferretta","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neulet.2017.09.051_bib0040","first-page":"718732","article-title":"Involvement of endocytosis and alternative splicing in the formation of the pathological process in the early stages of Parkinson\u2019s disease","volume":"2014","author":"Akh","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.neulet.2017.09.051_bib0045","doi-asserted-by":"crossref","first-page":"e43595","DOI":"10.1371\/journal.pone.0043595","article-title":"Biosignatures for Parkinson\u2019s disease and atypical parkinsonian disorders patients","volume":"7","author":"Potashkin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neulet.2017.09.051_bib0050","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1073\/pnas.0610204104","article-title":"Molecular markers of early Parkinson\u2019s disease based on gene expression in blood","volume":"104","author":"Scherzer","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neulet.2017.09.051_bib0055","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1186\/s12864-015-2058-3","article-title":"Blood transcriptomics of drug-naive sporadic Parkinson\u2019s disease patients","volume":"16","author":"Calligaris","year":"2015","journal-title":"BMC Genom."},{"key":"10.1016\/j.neulet.2017.09.051_bib0060","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1093\/brain\/awv202","article-title":"Association between \u03b1-synuclein blood transcripts and early, neuroimaging-supported Parkinson\u2019s disease","volume":"138","author":"Locascio","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.neulet.2017.09.051_bib0065","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ymthe.2004.05.021","article-title":"Differentiation and transcription factor gene therapy in experimental Parkinson\u2019s disease: sonic hedgehog and gli-1, but not Nurr-1, protect nigrostriatal cell bodies from 6-OHDA-induced neurodegeneration","volume":"10","author":"Hurtado","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.neulet.2017.09.051_bib0070","first-page":"855","article-title":"The role of transcription factor Pitx3 in dopamine neuron development and Parkinson\u2019s disease","volume":"9","author":"Li","year":"2009","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.neulet.2017.09.051_bib0075","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1091\/mbc.e06-02-0112","article-title":"Calsyntenin-1 docks vesicular cargo to kinesin-1","volume":"17","author":"Konecna","year":"2006","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.neulet.2017.09.051_bib0080","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1074\/jbc.M114.599852","article-title":"Cytoplasmic fragment of alcadein \u03b1 generated by regulated intramembrane proteolysis enhances amyloid \u03b2-protein precursor (APP) transport into the late secretory pathway and facilitates APP cleavage","volume":"290","author":"Takei","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2017.09.051_bib0085","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1016\/j.febslet.2015.07.017","article-title":"Stabilization of intracellular trafficking and metabolism of amyloid \u03b2-protein precursor and Alcadein \u03b2 by apolipoprotein E","volume":"589","author":"Kimura","year":"2015","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neulet.2017.09.051_bib0090","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1093\/hmg\/dds109","article-title":"Calsyntenin-1 mediates axonal transport of the amyloid precursor protein and regulates A\u03b2 production","volume":"21","author":"Vagnoni","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neulet.2017.09.051_bib0095","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/s12035-012-8369-3","article-title":"The central theme of Parkinson\u2019s disease: \u03b1-synuclein","volume":"47","author":"Ozansoy","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neulet.2017.09.051_bib0100","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1096\/fj.07-9348com","article-title":"Genetic variability in the SNCA gene influences \u03b1-synuclein levels in the blood and brain","volume":"22","author":"Fuchs","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.neulet.2017.09.051_bib0105","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0304-3940(94)90372-7","article-title":"Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson\u2019s disease","volume":"169","author":"Janetzky","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2017.09.051_bib0110","doi-asserted-by":"crossref","first-page":"7212","DOI":"10.1523\/JNEUROSCI.0711-11.2011","article-title":"The parkinsonian mimetic, MPP+, specifically impairs mitochondrial transport in dopamine axons","volume":"31","author":"Kim-Han","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2017.09.051_bib0115","first-page":"823","article-title":"Mitochondrial complex I deficiency in Parkinson\u2019s disease","volume":"54","author":"Schapira","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.neulet.2017.09.051_bib0120","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1111\/j.1471-4159.1990.tb05809.x","article-title":"Anatomic and disease specificity of NADH CoQ 1 reductase (complex I) deficiency in Parkinson\u2019s disease","volume":"55","author":"Schapira","year":"1990","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2017.09.051_bib0125","series-title":"Macromolecule & Acid, N. COX7B","author":"Surhone","year":"2011"},{"key":"10.1016\/j.neulet.2017.09.051_bib0130","doi-asserted-by":"crossref","first-page":"6626","DOI":"10.1021\/jm400287v","article-title":"New 5-aryl-1H-imidazoles display in vitro antitumor activity against apoptosis-resistant cancer models, including melanomas, through mitochondrial targeting","volume":"56","author":"Mathieu","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neulet.2017.09.051_bib0135","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/mds.870120104","article-title":"Defects of cytochrome c oxidase in the substantia nigra of Parkinson\u2019s disease: an immunohistochemical and morphometric study","volume":"12","author":"Itoh","year":"1997","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neulet.2017.09.051_bib0140","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1750-1326-9-17","article-title":"The Parkinsonian mimetic, 6-OHDA, impairs axonal transport in dopaminergic axons","volume":"9","author":"Lu","year":"2014","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neulet.2017.09.051_bib0145","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0022-510X(91)90311-T","article-title":"Respiratory chain abnormalities in skeletal muscle from patients with Parkinson\u2019s disease","volume":"104","author":"Bindoff","year":"1991","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neulet.2017.09.051_bib0150","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1083\/jcb.200804155","article-title":"Lamin B1 controls oxidative stress responses via Oct-1","volume":"184","author":"Malhas","year":"2009","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.neulet.2017.09.051_bib0155","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.freeradbiomed.2012.11.014","article-title":"Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease","volume":"62","author":"Yan","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neulet.2017.09.051_bib0160","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3233\/JAD-2008-15314","article-title":"Antioxidants in central nervous system diseases: preclinical promise and translational challenges","volume":"15","author":"Kamat","year":"2008","journal-title":"J. Alzheimers Dis. JAD"}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394017307930?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394017307930?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T08:26:16Z","timestamp":1536135976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394017307930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":32,"alternative-id":["S0304394017307930"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2017.09.051","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrated microarray analysis provided a new insight of the pathogenesis of Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2017.09.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}